Aerobic glycolysis activation through canonical WNT/β-catenin pathway in ALS

被引:6
|
作者
Vallee, Alexandre [1 ]
机构
[1] Univ Poitiers, CHU Poitiers, UMR CNRS 7348, LMA, 2 Rue Mileterie, F-86021 Poitiers, France
来源
M S-MEDECINE SCIENCES | 2018年 / 34卷 / 04期
关键词
AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL-CORD; SIGNALING PATHWAY; PYRUVATE-KINASE; WNT; PATHOGENESIS; BRAIN; METABOLISM; ISOFORM; TARGETS;
D O I
10.1051/medsci/20183404013
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Energy is the major determinant of neuronal viability. We focus our synthesis on the hypothesis of the development of aerobic glycolysis by the stimulation of the canonical WNT/beta-catenin pathway in amyotrophic lateral sclerosis (ALS). The stimulation of the canonical WNT/beta-catenin pathway induces the activation of aerobic glycolysis, also called Warburg effect, via the stimulation of glycolytic enzymes such as Glut (glucose transporter), PKM2 (pyruvate kinase M2), PDK1 (pyruvate dehydrogenase kinase 1), LDH-A (lactate dehydrogenase A) and MCT-1 (monocarboxylate transporter 1). The aerobic glycolysis consists to a supply of a large part of glucose into lactate regardless of oxygen. Aerobic glycolysis is less efficient in terms of ATP production than oxidative phosphorylation due to the shunt of the TCA cycle. Dysregulation of cellular energy metabolism promotes cell death and participates to the progression of ALS. Controlling the expression of the canonical WNT/beta-catenin signaling pathway is an attractive strategy to regulate aerobic glycolysis initiation and the progression of ALS.
引用
收藏
页码:326 / 330
页数:5
相关论文
共 50 条
  • [21] Canonical WNT/β-catenin pathway activation suppresses embryonal rhabdomyosarcoma growth and self-renewal
    Chen, Eleanor
    Deran, Michael
    Grandinetti, Katherine Brooke
    Ignatius, Myron
    Clagg, Ryan
    McCarthy, Karin
    Lobbardi, Riadh
    Wu, Xu
    Langenau, David
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [22] MFN2 knockdown promotes osteogenic differentiation of iPSC-MSCs through aerobic glycolysis mediated by the Wnt/β-catenin signaling pathway
    Deng, Lidi
    Yi, Siqi
    Yin, Xiaohui
    Li, Yang
    Luan, Qingxian
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [23] Canonical WNT/β;-catenin pathway activation suppresses embryonal rhabdomyosarcoma growth and self-renewal
    Chen, Eleanor
    DeRan, Michael
    Grandinetti, Katherine Brooke
    Ignatius, Myron
    Clegg, Ryan
    McCarthy, Karin
    Lobbardi, Riadh
    Wu, Xu
    Langenau, David
    CANCER RESEARCH, 2014, 74 (20)
  • [24] Determinants of thrombosis: activation of canonical Wnt pathway
    Borrell, M.
    Crespo, J.
    Pena, E.
    Badimon, L.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 : 127 - 127
  • [25] Wnt/β-catenin Pathway Activation In Lung Injury
    Russell, S. R.
    Lam, A.
    Flozak, A.
    Gottardi, C. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [26] Activation of Wnt/β-catenin signaling pathway in HNSCC
    Lindemann, A.
    Pries, R.
    Wollenberg, B.
    EJC SUPPLEMENTS, 2010, 8 (05): : 119 - 119
  • [27] Wnt9b signals through the canonical β-catenin pathway to induce kidney tubules
    Kamer, Courtney M.
    Carroll, Thomas J.
    DEVELOPMENTAL BIOLOGY, 2007, 306 (01) : 414 - 414
  • [28] Activation of the Canonical Wnt/β-Catenin Signalling Pathway is Rare in Canine Malignant Melanoma Tissue and Cell Lines
    Chon, E.
    Thompson, V.
    Schmid, S.
    Stein, T. J.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2013, 148 (2-3) : 178 - 187
  • [29] TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis
    Ramani, Nisha S.
    Aung, Phyu P.
    Gu, Jun
    Sfamenos, Steven
    Sdringola-Maranga, Chiara
    Nagarajan, Priyardhisini
    Tetzlaff, Michael T.
    Curry, Jonathan L.
    Ivan, Doina
    Diab, Adi
    Prieto, Victor G.
    Hwu, Wen-Jen
    Torres-Cabala, Carlos A.
    MODERN PATHOLOGY, 2020, 33 (10) : 2067 - 2074
  • [30] The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway
    Flahaut, M.
    Meier, R.
    Coulon, A.
    Nardou, K. A.
    Niggli, F. K.
    Martinet, D.
    Beckmann, J. S.
    Joseph, J-M
    Muehlethaler-Mottet, A.
    Gross, N.
    ONCOGENE, 2009, 28 (23) : 2245 - 2256